Insider Trading & Ownership of EcoR1 Capital, LLC

Notable person
Oleg Nodelman
Location
San Francisco, CA
Summary
The estimated value of insider holdings of EcoR1 Capital, LLC is at least $1,171,675,076 dollars as of 12 Jan 2026. EcoR1 Capital, LLC is the 10%+ Owner of Mirati Therapeutics, Inc. and owns shares of Mirati Therapeutics, Inc. stock worth about $436.57M. EcoR1 Capital, LLC is the Director, 10%+ Owner of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $341.95M. EcoR1 Capital, LLC is the Director, 10%+ Owner of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $102.05M. EcoR1 Capital, LLC is the 10%+ Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. stock worth about $85.51M. EcoR1 Capital, LLC is the 10%+ Owner of PROTHENA CORP PUBLIC LTD CO and owns shares of PROTHENA CORP PUBLIC LTD CO (PRTA) stock worth about $40.54M. EcoR1 Capital, LLC is the 10%+ Owner of Graphite Bio, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $34.84M. EcoR1 Capital, LLC is the 10%+ Owner of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $31.01M. EcoR1 Capital, LLC is the 10%+ Owner of Voyager Therapeutics, Inc. and owns shares of Voyager Therapeutics, Inc. (VYGR) stock worth about $27.54M. EcoR1 Capital, LLC is the 10%+ Owner of Adaptimmune Therapeutics PLC and owns shares of Adaptimmune Therapeutics PLC (ADAP) stock worth about $25.09M. EcoR1 Capital, LLC is the 10%+ Owner of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $24.84M. EcoR1 Capital, LLC is the 10%+ Owner of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $21.52M. EcoR1 Capital, LLC is the 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $198.6K.
Signature
/s/ Oleg Nodelman, Individually, and as Manager of EcoR1 Capital, LLC
All Insider Reports
All Insider Reports

Notify me when EcoR1 Capital, LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of EcoR1 Capital, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRTX Mirati Therapeutics, Inc. 10%+ Owner $436,569,701 18 Dec 2023
ZYME Zymeworks Inc. Director, 10%+ Owner $341,953,624 +$26,071,310 +8.3% 26 Jun 2025
ANAB ANAPTYSBIO, INC Director, 10%+ Owner $102,051,945 30 Dec 2024
ITOS iTeos Therapeutics, Inc. 10%+ Owner $85,511,824 +$38,685,562 +83% 14 May 2025
PRTA PROTHENA CORP PUBLIC LTD CO 10%+ Owner $40,544,618 -$50,839,807 -56% 02 May 2025
LENZ Graphite Bio, Inc. 10%+ Owner $34,836,860 06 Jan 2023
TNGX Tango Therapeutics, Inc. 10%+ Owner $31,010,920 06 Nov 2024
VYGR Voyager Therapeutics, Inc. 10%+ Owner $27,538,275 09 Jan 2023
ADAP, ADAPY Adaptimmune Therapeutics PLC 10%+ Owner $25,092,970 28 Jul 2025
TCRX TScan Therapeutics, Inc. 10%+ Owner $24,842,500 26 May 2023
MRSN Mersana Therapeutics, Inc. 10%+ Owner $21,523,200 19 Dec 2024
CRVS Corvus Pharmaceuticals, Inc. 10%+ Owner $198,639 30 Sep 2021
AKTS Aktis Oncology, Inc. Director 12 Jan 2026
ODTC Odonate Therapeutics, Inc. 10%+ Owner 01 Dec 2021

Insider Transactions Reported by EcoR1 Capital, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.